Hanson & Doremus Investment Management
Position in BMY — Bristol Myers Squibb Co
CIK 1393944
BURLINGTON, VT
Position in BMY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,046,206
-$138,106 QoQ
Shares Held
18,157
-7.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,137
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. BMY ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
|
35,388 | $852,143 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,046,206 | 18,157 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,184,312 | 19,527 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,000,910 | 18,556 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $785,687 | 17,421 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $841,922 | 18,188 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,152,528 | 18,897 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,095,793 | 19,374 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,030,195 | 19,911 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $968,894 | 23,330 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,625,923 | 29,982 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,712,266 | 33,371 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,045,155 | 35,237 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,327,204 | 36,391 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $2,429,246 | 35,049 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,685,893 | 37,330 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $2,381,230 | 33,496 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,625,161 | 34,093 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,526,326 | 34,593 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $2,162,547 | 34,684 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,027,519 | 34,266 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $2,642,196 | 39,542 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,366,933 | 37,493 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,482,688 | 40,024 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,383,987 | 39,542 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,324,070 | 39,525 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $2,339,017 | 41,963 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||